logo
Select company
Select metric
$ 35.56MNet Cash Flow - Financing
VS
Market
24
Sector
24
Industry
31
History
50
$ 1.73Close
$ 0.61 - $ 16.96 52-Week Range
Ticker Information

Ticker

NMRA

Company Name

NEUMORA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

NEUMORA THERAPEUTICS INC - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NMRA - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ 35.56M
3/31/2025$ 19.76M
12/31/2024$ 21.6M
9/30/2024$ 5.55M
6/30/2024$ 236.04M
12/31/2023$ 231.94M
12/31/2022$ 115.74M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NEUMORA THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Financing stands at $ 115.74M.
  • Over the past 5 years, NEUMORA THERAPEUTICS INC's average CF - Financing has been $ 95.17M.
  • The median CF - Financing for NEUMORA THERAPEUTICS INC during this period was $ 35.56M
  • NEUMORA THERAPEUTICS INC reached its highest CF - Financing over the past 5 years at $ 236.04M.
  • The lowest CF - Financing recorded by NEUMORA THERAPEUTICS INC in the same timeframe $ 5.55M

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

NMRA - Net Cash Flow - Financing, Last 5 years

$ 5.55M

Minimum

Sep 30, 2024

$ 236.04M

Maximum

Jun 30, 2024

$ 95.17M

Average

$ 35.56M

Median

CF - Financing Benchmark Analysis

The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.74M with a standard deviation of $ 119.11M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.23K
min$ -367.1M
max$ 366M
average$ -6.74M
median$ 314K
std$ 119.11M